Trial Details

COMPLETED
Basic Information
Clinical ID c4503
Identifier NCT00410410
Trial Title A Study of Abatacept in Patients With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: abatacept (ABA)|DRUG: placebo|DRUG: abatacept
Participant Information
Sponsor Bristol-Myers Squibb
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2006-12
Primary Completion Date 2009-06
Completion Date 2009-11